KRC KRC (Cefaclor 250 mg)
Pill imprint KRC KRC has been identified as Cefaclor 250 mg.
Cefaclor is used in the treatment of bronchitis; urinary tract infection; bladder infection; upper respiratory tract infection; kidney infections (and more), and belongs to the drug class second generation cephalosporins. There is no proven risk in humans during pregnancy. Cefaclor 250 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- KRC KRC
- Strength:
- 250 mg
- Color:
- Blue & Pink
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Second generation cephalosporins
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Alvogen, Inc.
- National Drug Code (NDC):
- 47781-0266
- Inactive Ingredients:
- magnesium stearate
lactose monohydrate
magnesium silicate
sodium glycolate
gelatin
titanium dioxide
FD&C Blue No. 1
FD&C Red No. 3
| NDC Code | Manufacturer / Repackager |
|---|---|
| 61442-0171 | Carlsbad Technology, Inc. |
| 60429-0701 | Golden State Medical Supply (repackager) |
Note: Inactive ingredients may vary.
More about cefaclor
Consumer resources
- Other brands: Raniclor
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
